P. Richard Harrigan - Concepedia

Author

P. Richard Harrigan

Also Known As

A M Hill, Harrigan, P.R., P Harrigan, P R Harrigan, P R. Harrigan, P Richard Harrigan, P. Harrigan, P. R. Harrigan, P. Richard Harrigan, P.R. Harrigan

312

Publications

16.8K

Citations

H-Index

117

Concepts

All Affiliations

AIDS Vancouver University of British Columbia St. Paul's Hospital Simon Fraser University Harvard University

About

P. Richard Harrigan is an author at AIDS Vancouver specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	56	4.3K
2	Public Health	15	18	1.5K
3	Natural Sciences	9	9	609
4	Biology	3	3	159
5	Engineering	2	2	87

P. Richard Harrigan

200

Publications

14.9K

Citations

H-Index

Page 1

	Year	Citations
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study Julio Montaner, Viviane D. Lima, Rolando Barrios, The Lancet Preventive MedicineEpidemiological OutcomeTreatment And PreventionBritish ColumbiaNew Hiv Diagnoses	2010	777
Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy Brendan Larder, Sharon D. Kemp, P. Richard Harrigan Science	1995	633
Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients Hélène C. F. Côté, Zabrina L. Brumme, Kevin J.P. Craib, New England Journal of Medicine	2002	572
Adaptation of HIV-1 to human leukocyte antigen class I Yuka Kawashima, Katja Pfafferott, John Frater, Nature Primary ImmunodeficiencyHuman RetrovirusImmunologyAntiviral ResponseHiv	2009	464
Predictors of HIV Drug‐Resistance Mutations in a Large Antiretroviral‐Naive Cohort Initiating Triple Antiretroviral Therapy P. Richard Harrigan, Robert S. Hogg, Winnie Dong, The Journal of Infectious Diseases	2005	433
Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 10<sup>9</sup> cells/L Evan Wood, Robert S. Hogg, Benita Yip, Annals of Internal Medicine	2003	362
Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting Julio Montaner, Viviane D. Lima, P. Richard Harrigan, PLoS ONE	2014	355
Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration Rami Kantor, David Katzenstein, Brad Efron, PLoS Medicine	2005	318
Adherence–resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness David R. Bangsberg, Edward P. Acosta, Reena Gupta, AIDS	2006	315
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy Viviane D. Lima, Robert S. Hogg, P. Richard Harrigan, AIDS	2007	280

Page 1